NPI registry status
Active
2026 NPPES data Pulmonary Disease Physician NPI 1013005503 M.D.
Verify on CMS → Daniel Dea, M.D.
Pulmonary Disease Physician in Burbank, California.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 9,323 in Pulmonary Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
4K
Medicare Part D claims · 338 beneficiaries · Pulmonary Disease Physician avg: 1K
Generic prescribing
63%
generic claims · 36% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
28.4/100
▼ 55 pts below national avg 83.1 · Below average
Industry payments
$2.8K
82 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Daniel Dea, M.D. reported a CMS MIPS final score of 28.4/100 - below the 83.1 national average - and filed 3,879 Medicare Part D claims in 2023.
- 28.4/100
- MIPS score · -55 vs avg
- 4K
- Part D claims, 2023
- 63%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Daniel Dea, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
28 3rd percentile higher than 3% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Daniel Dea, M.D. sits
This provider among pulmonary disease physician peers
Across the 2,676 pulmonary disease physician providers who report both Medicare Part D prescribing and a MIPS quality score, Daniel Dea, M.D. writes more Part D claims than 89% of them and scores higher on MIPS quality than 5% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one pulmonary disease physician peer from a representative sample of 60; the gold marker is Daniel Dea, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Daniel Dea, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Daniel Dea, M.D.?
Below national averagePrimary specialty
Pulmonary Disease Physician
Medicare Part D claims
3,879 166% vs specialty avg
MIPS final score
28.4/100 54.7 pts vs avg
Specialty distribution in California
How Pulmonary Disease Physician compares to other specialties among California providers
Medicare quality performance, MIPS
Daniel Dea, M.D.'s 2023 MIPS final score plotted against the Pulmonary Disease Physician national average
- MIPS Final Score
- 28.4/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Pulmonary Disease Physician) - 28.4/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Daniel Dea, M.D. appears in the CMS NPPES registry as a Pulmonary Disease Physician provider holding M.D. credentials at 2701 W ALAMEDA AVE, Burbank, CA, 91505, with a listed phone of (818) 846-2766. NPI 1013005503 was issued on 10/10/2006.
Medicare Part D records for calendar year 2023 show 3,879 prescription claims written by this provider, covering 338 Medicare beneficiaries and totaling roughly $2.2 million in drug spend, split 36% brand-name and 63% generic by claim count, with an opioid prescribing rate of 2.0%. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 28.4/100 for the 2023 performance year, compared with the national average of 83.1.
Pulmonary Disease Physician is a mid-sized specialty nationwide, with 9,323 enrolled providers across 53 states and an average of 1,457 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1013005503 |
|---|---|
| Specialty | Pulmonary Disease Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 10/10/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
28.3917
Final Score
Avg: 83.1
56.7834
Cost
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Daniel Dea, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$2.8K
Largest payer
AstraZeneca Pharmaceuticals LP
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - California MBC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 - they are NOT specific to Daniel Dea, M.D.. To verify Daniel Dea, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
Daniel Dea, M.D. - brand share 36.0%
Pulmonary Disease Physician average
36% brand-name claims vs 63% generic, on 3,879 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
3,879
Total Claims
$2.2M
Total Drug Cost
338
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 4,942
- Total Day Supply
- 127,503
- Brand vs Generic
- 36% brand / 63% generic
- Brand Drug Cost
- $2.1M
- Generic Drug Cost
- $90K
- Opioid Claims
- 77 (2.0% rate)
- Antibiotic Claims
- 169
Patient Demographics
- Average Patient Age
- 76.8 years
- Avg HCC Risk Score
- 1.94
- Gender Split
- 57% female / 43% male
- Age Distribution
- <65: 17, 65-74: 132, 75-84: 109, 85+: 80
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Daniel Dea, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Trelegy Ellipta
Trelegy Ellipta
374 claims
- Albuterol Sulfate … 145
Albuterol Sulfate Hfa
145 claims
- Atorvastatin Calcium 139
Atorvastatin Calcium
139 claims
- Prednisone 138
Prednisone
138 claims
- Breo Ellipta 113
Breo Ellipta
113 claims
- Furosemide 111
Furosemide
111 claims
- Potassium Chloride 110
Potassium Chloride
110 claims
- Losartan Potassium 105
Losartan Potassium
105 claims
| Drug | Claims |
|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 374 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 145 |
| Atorvastatin Calcium | 139 |
| Prednisone | 138 |
| Breo Ellipta Fluticasone/Vilanterol | 113 |
| Furosemide | 111 |
| Potassium Chloride | 110 |
| Losartan Potassium | 105 |
| Amlodipine Besylate | 98 |
| Eliquis Apixaban | 97 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pulmonary Disease Physician Overview
How Daniel Dea, M.D. fits within the Pulmonary Disease Physician landscape nationally.
9,323
Pulmonary Disease Physician Providers in US
53
States with Pulmonary Disease Physician
1,457
Avg Claims per Provider
Daniel Dea, M.D.'s 3,879 claims are above the specialty average of 1,457.
Nearby Pulmonary Disease Physician Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Dea.
Dr. Manoochehr Abadian Sharifabad
M.D.
Fountain Valley, CA
Dr. Mohamad Abdelfattah
MD
Fullerton, CA
Dr. Zainab Abdulsada
MBCHB
Sacramento, CA
Dr. Ayham Aboeed
M.D.
Bakersfield, CA
Dr. Babak Abrishami
D.O.
Los Angeles, CA
Compare Pulmonary Disease Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the California medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Pulmonary Disease Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore California
Frequently Asked Questions
What is Daniel Dea, M.D.'s specialty? ▼
Daniel Dea, M.D. specializes in Pulmonary Disease Physician and practices in Burbank, California. Credentials: M.D..
How much does Daniel Dea, M.D. prescribe under Medicare Part D? ▼
In 2023, Daniel Dea, M.D. wrote 3,879 Medicare Part D claims totaling $2.2M in drug costs for 338 beneficiaries.
What is Daniel Dea, M.D.'s Medicare quality score? ▼
Daniel Dea, M.D. has a CMS MIPS Final Score of 28.4/100, Cost: 56.8. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Daniel Dea, M.D. located? ▼
Daniel Dea, M.D. is located at 2701 W ALAMEDA AVE, Burbank, CA, 91505. Phone: (818) 846-2766.
What is Daniel Dea, M.D.'s NPI number? ▼
Daniel Dea, M.D.'s National Provider Identifier (NPI) is 1013005503, issued on 10/10/2006.
Does Daniel Dea, M.D. prescribe more brand-name or generic drugs? ▼
Daniel Dea, M.D.'s prescribing is 36% brand-name and 63% generic drugs by claim count, with $2.1M in brand drug costs.
Does Daniel Dea, M.D. prescribe opioids? ▼
Yes, Daniel Dea, M.D. had 77 opioid claims in 2023 with an opioid prescribing rate of 2.0%.
How many Pulmonary Disease Physician providers are there in the US? ▼
There are 9,323 Pulmonary Disease Physician providers across 53 states in the US. The average Pulmonary Disease Physician provider writes 1,457 Medicare Part D claims per year.
What drugs does Daniel Dea, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Daniel Dea, M.D.'s most frequently prescribed drugs include Trelegy Ellipta, Albuterol Sulfate Hfa, Atorvastatin Calcium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Daniel Dea, M.D. accept Medicare? ▼
Daniel Dea, M.D. appears in CMS Medicare data with 3,879 Part D claims and 338 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Daniel Dea, M.D.'s credentials? ▼
Daniel Dea, M.D.'s NPI is 1013005503 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.